Supply Chain Manager

JAKE FELDMAN, Ph.D.

**** **** **** ****** ****: *18-951-659

6

Brooklyn, NY 11210 *********@*****.*** Cell: 718-724-909

1

SUMMARY

A strategically-focused Transfer Pricing Practice Leader and Senior Tax

Executive/Advisor with extensive experience in tailoring business

structures to the multinational environment and a record of significant

accomplishments in business development, international taxation,

intellectual property planning, supply chain structures, treasury

management and strategic financial analysis.

. Defended global multi-billion dollar logistics client in transfer pricing

controversy with IRS that not only avoided tax adjustment but resulted in

multi-million dollar future tax reduction.

. Commended by operating division heads for providing astute business

advice, and negotiating/executing corporate development, tax and

financing transactions that provided hundreds of millions of dollars in

benefits.

. Served clients in a broad range of industries, including

software/internet, consumer and industrial goods, pharmaceuticals,

financial institutions, energy, services and transportation.

. Led large-scale international multi-disciplinary task force teams and

traveled extensively throughout Asia, Australia/New Zealand, Europe,

Latin America, Africa and the Middle East.

EXPERIENCE

GLOBAL TAX ADVISORY GROUP, New York, NY

Managing Director 2010-Present

Founded independent international tax and transfer pricing consultancy.

. Engaged by $700 million specialty chemical client regarding a principal

hub supply chain restructuring plan and transfer pricing study.

. Advising $300 million biotech client on an intangibles migration

strategy.

. Providing adhoc transfer pricing advice to $300 million European

multinational consumer goods company.

. Provided tax planning advice to multi-billion dollar Wall Street firm

regarding Puerto Rico tax structures.

. Assisted billion dollar management consulting firm with planning for tax-

effective supply chain structures.

GRANT THORNTON LLP, New York, NY

Executive Director, Transfer Pricing Practice Leader 2007-2009

Practice leader, subject matter consultant and controversy expert for the

Northeast region of this global accounting and tax firm. Directed and

trained team of 4 consultants in all aspects of business development,

managing client relationships and interacting with client CFOs and Tax

Directors. Provided advice to clients and colleagues nationwide regarding

technical guidance, IRS controversy and audit defense, economic analysis,

strategic tax planning and tax structures in connection with intercompany

transactions including goods, services, financing, intangibles and cost

sharing.

. Grew practice revenue by 20% to $2.0 million range despite economic

downturn through a combination of internal cross-selling, business

development with both existing and new clients, and thought leadership.

. Successfully advised billion dollar pharmaceutical client in tax

controversy concerning several collaboration and development

arrangements, royalties, manufacturing, distribution and corrected tax

return filings.

. Defended international satellite systems client in IRS audit of its

intangibles migration, research sharing, manufacturing and distribution

arrangements that resulted in no tax adjustments.

. Developed transfer pricing strategy and financial entity structures for a

software client to support its international expansion in the Asia,

Europe and Middle East regions.

. Implemented new process to improve interaction with clients in the

conduct of financial audit FIN 48, tax provision and tax return reviews

of their transfer pricing positions.

MERCK & CO., INC., Whitehouse Station, NJ

Senior Director, International Tax Planning 2001-2006

Provided worldwide tax planning services supporting divisional, product

franchise, joint venture and transfer pricing activities for this $45

billion leading multinational pharmaceutical company. Generated $900

million through a combination of tax savings and risk avoidance including:

. Accomplished $500 million tax benefit through the financial analysis,

development and documentation of an innovative large-scale transfer

pricing study for inbound sales to the US.

. Realized $100 million in tax savings and reduced inventories through

leading a team of 30 individuals, including external legal and tax

advisors, to implement a tax-effective hub supply chain structure in

Latin America. Overcame complex regulatory challenges related to contract

manufacturing, VAT, customs and health ministry rules.

. Mitigated $100 million customs and tax exposure by design of an

alternative supply chain.

Senior Director/Director, Global Entity Management 1998-2001

Established new department and built a team of professionals with world-

class financial abilities to direct Merck's world-wide transfer pricing and

entity management functions (with over 200 foreign affiliates) encompassing

entity profitability, product supply chains and intercompany arrangements.

. Generated $190 million tax benefit by altering the flow of intercompany

trademark and know-how royalties.

. Reduced inventories by $50 million as head of task force to evaluate and

implement a Singapore-based hub supply chain concept for the Asia-Pacific

region.

. Introduced the company's first global transfer pricing policy and

procedure, developed company-wide intercompany transaction grants of

authority, implemented intercompany agreements, instituted new internet-

based systems and supervised numerous transfer pricing studies.

Director, International Treasury - Latin America, Middle East & Africa

1992-1998

Director, International Treasury - Latin America 1985-1992

Supervised 20 of Merck's subsidiary financial directors and controlled the

major portion (up to $50 million) of the company's annual foreign exchange

and interest expense budget.

. Improved profitability by over $20 million in the emerging markets of

Latin America, Asia, Middle East and Africa by supporting operating

executives in the restructuring or establishment of subsidiary

operations, including negotiation of joint venture, divestiture,

licensing and supply arrangements.

. Appointed to joint ventures' Board of Directors after successfully

negotiating and implementing new ventures in Mexico and Brazil.

. Contributed to the design and model development of Merck's foreign

currency option hedging program and led effort to design its short and

long-term entity forecasting system.

Director, Capital Evaluations 1977-1985

Manager, Corporate Financial Analysis

Manager, International Controller Operations

Associate, Operations Research

. Applied Monte Carlo simulation to the analysis of the company's major

product investments that became the foundation for a company-wide R&D

strategic planning system still utilized by senior management.

NEW YORK UNIVERSITY, LEONARD N. STERN SCHOOL OF BUSINESS

Adjunct Assistant Professor of Finance 1977-1982

EDUCATION

NEW YORK UNIVERSITY, LEONARD N. STERN SCHOOL OF BUSINESS

Ph.D. - Finance and Operations Research, Research and Teaching Fellow, 1977

CITY COLLEGE OF NEW YORK

B.S. with Honors (summa cum laude) - Physics and Mathematics, 1973

Class Rank: First in Class; Phi Beta Kappa; Sonkin and Ward Medals in

Physics

PROFESSIONAL

. Chair for Executive Enterprise Institute's Pharma/Biotech Finance

Conferences

. Presented at Tax Executives Institute, Knowledge Congress, Economist and

Baker & McKenzie conferences on transfer pricing, supply chain

structures, tax strategies, restructuring activities and currency

hedging.

. Editorial Advisory Board for past publications covering business and

finance in emerging markets for WorldTrade Executive and the Economist

Intelligence Unit

. American Bar Association Tax Section, AICPA, International Fiscal

Association

. Mentor - NYU Stern and Merck

. Judged NY Academy of Sciences School Science Fairs

. Judged Merck Worldwide Finance Innovation Awards

Contact this candidate